Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTAIN-T2D: Clofutriben in Type 2 Diabetes
NCT07296484Phase 2Recruiting
- Sponsor
- Sparrow Pharmaceuticals
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clofutriben in type 2 diabetes mellitus (T2DM), Cushing's syndrome, sponsored by Sparrow Pharmaceuticals. Started Nov 2025; status: recruiting.
02
Drugs
clofutriben
03
Conditions
type 2 diabetes mellitus (T2DM)Cushing's syndrome
Beyond the preview
Go deeper on NCT07296484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296484.